Veru Inc (VERU)
1.21
-0.11
(-8.33%)
USD |
NASDAQ |
Apr 25, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 20:00
Veru Total Liabilities (Quarterly): 28.96M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 28.96M |
September 30, 2023 | 30.34M |
June 30, 2023 | 40.81M |
March 31, 2023 | 53.54M |
December 31, 2022 | 54.68M |
September 30, 2022 | 52.56M |
June 30, 2022 | 43.71M |
March 31, 2022 | 36.83M |
December 31, 2021 | 24.16M |
September 30, 2021 | 25.85M |
June 30, 2021 | 25.10M |
March 31, 2021 | 25.66M |
December 31, 2020 | 24.04M |
September 30, 2020 | 21.43M |
June 30, 2020 | 23.91M |
March 31, 2020 | 24.76M |
December 31, 2019 | 24.89M |
September 30, 2019 | 21.30M |
June 30, 2019 | 19.10M |
March 31, 2019 | 17.47M |
December 31, 2018 | 15.45M |
September 30, 2018 | 18.97M |
June 30, 2018 | 17.60M |
March 31, 2018 | 16.86M |
December 31, 2017 | 6.298M |
Date | Value |
---|---|
September 30, 2017 | 6.883M |
June 30, 2017 | 24.61M |
March 31, 2017 | 23.64M |
December 31, 2016 | 25.32M |
September 30, 2016 | 4.690M |
June 30, 2016 | 5.108M |
March 31, 2016 | 5.042M |
December 31, 2015 | 4.597M |
September 30, 2015 | 4.339M |
June 30, 2015 | 4.789M |
March 31, 2015 | 4.838M |
December 31, 2014 | 3.657M |
September 30, 2014 | 3.608M |
June 30, 2014 | 3.708M |
March 31, 2014 | 5.459M |
December 31, 2013 | 5.231M |
September 30, 2013 | 3.767M |
June 30, 2013 | 5.145M |
March 31, 2013 | 6.628M |
December 31, 2012 | 6.003M |
September 30, 2012 | 6.228M |
June 30, 2012 | 5.498M |
March 31, 2012 | 5.391M |
December 31, 2011 | 4.398M |
September 30, 2011 | 2.690M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.10M
Minimum
Jun 2019
54.68M
Maximum
Dec 2022
31.67M
Average
25.66M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | 88.86M |
Regeneron Pharmaceuticals Inc | 7.107B |
Bio-Path Holdings Inc | 2.779M |
Aileron Therapeutics Inc | 99.12M |
Scholar Rock Holding Corp | 85.82M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 80.57M |
Shareholders Equity (Quarterly) | 51.60M |
Debt to Equity Ratio | 0.1881 |
Current Ratio | 3.209 |
Net Debt Paydown Yield | 0.21% |